needs in Biological Technology

CoreRx, Inc. Announces Plans for Expansions to Meet the Needs of Growing Pharmaceutical Formulation Development Business

Formulation Development firm CoreRx announces new facility which will add capacity, additional capabilities to growing laboratory in order to meet growing customer demands. Tampa, FL (Vocus) June 15, 2009 -- CoreRx, Inc. has announced plans to purchase a new facility wh...

TechConnect World 2009 Matches Tomorrow's Technology Solutions with Today's Business Needs for Clean-Technology, Biotechnology and Nanotechnology

The Largest Technology Matchmaking Event in the US Comes to Houston, May 3-7, 2009 at the George R. Brown Convention Center HOUSTON, Oct. 27 /PRNewswire/ -- The Nano Science and Technology Institute (NSTI), and the Clean Technology and Sustainable Industries Organization (CTSI), toda...

International Council on Nanotechnology launches global research needs assessment

WASHINGTON - As nanotechnology has moved out of the laboratory and into commercial products, many have begun to question the impact of nanoscale materials on health and the environment. Learning more about such impacts, however, presents a daunting task, given the number of potential products, th...

Baxter and Its Foundation Contribute Nearly $53 Million in 2007 to Address Critical Needs Locally and Globally

DEERFIELD, Ill., March 10 /PRNewswire/ -- Baxter International Inc. and The Baxter International Foundation, the philanthropic arm of Baxter, today announced their combined 2007 charitable giving, which focused on increasing access to healthcare, helping developing nations and countries in cri...

Unmet Needs Provide Challenges and Opportunities for Rheumatoid Arthritis Drug Developers According to MedPredict Report

SCOTTSDALE, Ariz., Feb. 26 /PRNewswire/ -- MedPredict Market Research, a global provider of pharmaceutical competitive intelligence and market research, has published a new report providing critical strategic insight for pharma and biotech companies with a stake in the market for Rheumatoid Ar...

Biotechnology Needed to Help Meet Growing Global Needs for Food, Feed, Fuel and Materials, DuPont Chairman & CEO Says at World Food Prize

DES MOINES, Iowa, Oct. 19 /PRNewswire-FirstCall/ -- DuPont Chairman and CEO Charles O. Holliday, Jr., today told participants at the World Food Prize that biotechnology will enable the world to keep pace with the rapid growth in global demand for food, feed, fuel and materials. "Biotechnology...

Oxygen Biotherapeutics, Inc. Signs Supply Agreement for Clinical-Grade Oxycyte for Clinical Trials and Future Needs

COSTA MESA, Calif., April 14 /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBO) today announced it has reached a development and commercial supply agreement with Hospira Inc.'s One 2 One(R) Global Pharmaceutical Services business unit to manufacture clinical-grade Ox...

My View - State Government Needs Integrity To Build Investor Confidence

I applaud Senator Ted Kanavas for his desire to align best business practices to state government. I was also pleasantly surprised to see the senator refer to the Sarbanes-Oxley Act of 2002 (Sarbox) in his recent WTN exclusive interview. Lets look at this concept a little closer. President Bush sig...

Wisconsin Needs More Investment Capital

MADISON Practical ideas for spurring capital investment are included in economic development plans released this week by Gov. Jim Doyle and state Senate Republicans, said Tom Still, president of the Wisconsin Technology Council. The Grow Wisconsin plan unveiled by the Governor and the package r...

Special needs addressed at Web Usability Conference

MADISON Madisons masters of online usability challenged businesses to better meet the needs of customers and individuals with special needs last Wednesday at a Web usability conference titled Are Your Web Based Solutions Accessible, Effective and Useable? The conference, which was hosted by the...

Wisconsin's paper industry needs technology, innovation to prosper.

Source: Wisconsin Paper Council APPLETON, Wis. Foreign competition has threatened Wisconsin's paper mills, which must employ the latest technology and find new marketsor slowly perish. That may read like today's headlines, but it's a story from 1911. It still serves as an example. A centu...

Big Pharma already has a generic strategy, but needs new direction

In his February 14, 2005 article, Michael Rosen argues that Big Pharma "will be forced into generic-drug strategy," and suggests that this will be a good thing. But Big Pharma already has a generic drug strategy for traditional pharmaceuticals. This strategy has not been particularly good for ...

Healthcare needs of hurricane-hit region being monitored by West Allis company's system

West Allis, Wis. -- A Web-based system known as the Critical Infrastructure Data System (CIDS), developed by EMSystem of West Allis is being used to monitor healthcare critical needs and operational issues in the multi-state region that continues to be affected by hurricanes Katrina and Rita. ...

State web site needs overhaul

Madison, Wis. It's a state website for the new century, complete with RSS news feeds, podcasts and automatic e-mail notifications of everything important to the average person, such as school closings, unexpected pollutant releases and changes in the status of known sex offenders. It's easy on ...

Broadband access needs a champion, FCC commissioner says

Milwaukee, Wis. The United States ranks a dismal 16th worldwide in broadband deployment largely because it lacks a national broadband strategy, a member of the Federal Communications Commission said Tuesday. Speaking before the ninth annual Midwestern Telecommunications and Technology Confere...

Clinton says world needs biofuels, GM crops, and more answers

Chicago The biotechnology industry has a job to do, former president Bill Clinton said on Tuesday at a luncheon attended by thousands at the BIO Chicago conference. He called on the industry to reduce the spread of infectious diseases, guard against pandemics, create crops that can feed more ...

Researchers say scientific reporting needs more perspective, less hype

Fitchburg - A scientist who was involved in the cloning of Dolly the sheep said Thursday there often is a lack of perspective in media coverage of embryonic stem cell research, which could be raising the publics expectations that medical breakthroughs are just around the corner when they are at l...

Why Milwaukee needs its own thriving research base

Don't suggest to UW-Milwaukee Chancellor Carlos Santiago that research projects on his campus will get ahead by pilfering from programs at UW-Madison. He'll probably laugh at you. "Let's get real," Santiago told listeners at a recent Madison forum on the future of higher education in Wisconsin. ...

To be a player in the "Knowledge Economy," Wisconsin needs more tech workers

Madison, Wis . If Wisconsin continues to build on its technology strengths, will its economic weaknesses eventually take care of themselves? Wisconsin's assets in the 21st century knowledge economy are impressive when compared with other states of its size. But its weaknesses are intimidating...

WiscNet members choose anti-spam products for different needs

Members of WiscNet , a non-profit cooperative that networks Wisconsin institutions, took different directions in choosing anti-spam software after a test conducted with eWeek last September, the magazine has reported. After months of seeking out anti-spam systems, examining more than 30 respo...

Wisconsins tax system must adapt to meet changing technology needs

The first study of Wisconsins tax burden in 25 years was designed to answer one overriding question: Is that burden fairly distributed among the rich, the middle class and the poor? The conclusion, announced last week, was a mildly convincing yes &mndash; but that wont be the end of Wisconsins neve...

Wisconsin can offer what a federal energy research lab needs

Madison, Wis. - Researchers and engineers across Wisconsin are learning new ways to produce energy from cow manure, wood chips, organic sugars, soybeans, solar collectors, corn stover, wind farms, grease, waste from paper mills, and much more. State businesses, architects, and builders are n...

Custom RNA & RNA Isolation Services to Meet Your Specific Needs

Experienced staff designated for custom orders Flexible, optimized protocols to meet your specific needs Established network of ethical Tissue Procurement P...

SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights

...nch of the Compact 96 system the company continues to make improvements to its MassARRAY platform. This next generation MassARRAY system addresses the needs of lower throughput laboratories. The combination of the features of the new MassARRAY Compact 96 system - accuracy, sensitivity, and now the ability ...

OncoGenex Reports Second Quarter 2009 Financial Results

...x Pharmaceuticals OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address unmet needs in the treatment of cancer. OncoGenex has a deep oncology pipeline, with each product candidate having a distinct mechanism of action and representing...

One of the Nation's Leading Analytical Testing Laboratories is Now Easier to Access -- Pace Analytical Launches New Web Site to Showcase Its Three Business Divisions

... device testing, and onsite laboratory operation and management services. Pace Analytical's laboratory network performs services designed to cover the needs of a diverse range of businesses, industries and government sectors. ### Read the full story at http://www.prweb.com/releases/2009/08/prweb27105...

Webcast Alert: Transgenomic Inc. Announces Second Quarter 2009 Earnings Release Conference Call Webcast

...nd expertise to provide a menu of mutation scanning tests for over 700 cancer-associated genes and more than 60 validated diagnostic tests to meet the needs of pharmaceutical and biotech companies, research and clinical laboratories, physicians and patients. For more information about the innovative system...

PharmAthene to Host Second Quarter 2009 Conference Call and Webcast on Thursday, August 13, 2009

...l be available for 30 days, or until approximately September 12, 2009. About PharmAthene, Inc. PharmAthene was formed to meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biological and chemical weapons. PharmAthene's l...

Curis and Debiopharm Sign an Exclusive License Agreement Covering the HSP90 Inhibitor CUDC-305

...ncer treatment and Debiopharm Group (Debiopharm), a group of companies with a focus on the development of prescription drugs that target unmet medical needs today announced that they have entered into a worldwide, exclusive license agreement for Curis' Heat Shock Protein (Hsp90) technology, including CUDC-...

Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results

...rent beliefs and expectations. Forward-looking statements include statements regarding: the company's belief that Acetavance may fulfill unmet medical needs or enhance patient care, the timeframe in which Cadence anticipates receiving regulatory approval for Acetavance, and the company's financial projecti...

SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2009 FINANCIAL RESULTS

...age, healthcare, and other products," Snyder stated. "We are encouraged by the data from our recent taste tests and the possibility of addressing the needs of potential new collaborators." Senomyx is also continuing to increase the number of granted patents in its intellectual property portfolio of...

Zeus Expands International Support With New Hires

...nd will allow him to quickly acclimate to Zeus and the application-specific needs of our international partners," said Alan Andrews, Zeus Senior Vice Preside...egy to facilitate further growth in the European market and better meet the needs of our international partners." About Zeus, Inc.: Zeus, Inc...

VIVUS to Present at the Canaccord Adams 29th Annual Global Growth Conference

...p://www.vivus.com . About VIVUS VIVUS is a biopharmaceutical company developing innovative, next-generation therapies to address unmet needs in obesity, diabetes and sexual health. The company's lead investigational product in clinical development, Qnexa(TM), is expected to complete Phase 3...

OmniComm Systems Acquires EDC Assets of Leading Phase I Clinical Software Vendor - Logos Technologies, Ltd.

...in 2010 for electronic data capture in the phase I sector alone. Solutions for a phase I specific environment must be developed to meet their unique needs and the Logos products are designed specifically for this need. About Logos Technologies, Ltd. Logos Technologies, Ltd. is one of the ...

New Director of Lab Sales for Polymathic Analytical Labs

...ithin competitive markets," said Chris Given, Laboratory Manager. "With Bill's expertise and proven track record, we will be better able to assess the needs of our partners, meet customer demands and maintain lasting business relationships." Kerr is a graduate of the University of Pittsburgh with a ...

Bionovo, Inc. to Announce Second Quarter Fiscal Year 2009 Financial Results on Monday, August 10, 2009

...utical company focused on the discovery and development of safe and effective treatments for women's health and cancer, markets with significant unmet needs and billions in potential annual revenue. The company applies its expertise in the biology of menopause and cancer to design new drugs derived from bo...

OncoGenex Pharmaceuticals to Release Second Quarter 2009 Financial Results

...x Pharmaceuticals OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address unmet needs in the treatment of cancer. OncoGenex has a deep oncology pipeline, with each product candidate having a distinct mechanism of action and representing...

Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo(R) in the United States

...Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in neuroscience. For further information, please visit the company's website at: www.transcept.com . About Purdue Purdue Pharma L.P. a...

Nektar Therapeutics to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference in New York City

...ading biopharmaceutical companies. Nektar is also developing a robust pipeline of its own potentially high-value therapeutics to address unmet medical needs by leveraging and expanding its technology platforms to improve and enable molecules. The company recently announced positive Phase 2 results ...

Nektar to Announce Financial Results for the Second Quarter of 2009 on Tuesday, August 4, 2009, After Close of U.S.-Based Financial Markets

...ading biopharmaceutical companies. Nektar is also developing a robust pipeline of its own potentially high-value therapeutics to address unmet medical needs by leveraging and expanding its technology platforms to improve and enable molecules. The company recently announced positive Phase 2 results for O...